Historian claims to have solved King Arthur mystery

D F Carroll with his book Arturius: A Quest For Camelot

£50,000 to anyone who can prove him wrong

There is no doubt in my mind that Arturius is the real King Arthur.”

— David F Carroll

HULL, EAST RIDING OF YORKSHIRE, UNITED KINGDOM, July 2, 2018 /EINPresswire.com/ — Historian claims to have solved King Arthur mystery with 1300-year-old Swiss manuscript

A historian believes he has found proof that the legendary King Arthur was actually the son of a 6th century Scottish king – and is offering £50,000 to anyone who can prove him wrong.

David Carroll, has spent more than twenty- five years researching the legend of King Arthur, a quest that has taken him all over Europe delving into ancient manuscripts and records.

After finding a manuscript hidden away under lock and key in the town library of Schaffhausen in Switzerland, the historian believes he has irrefutable proof that a sixth-century Scottish prince is the true source of the Arthurian legend.

The Dorbene manuscript, written by 7th century monks, is the oldest historical document in the world to mention Arthur.

David says the similarities between the Scottish battle leader Arthur documented in the manuscript and the legend of King Arthur cannot be ignored.

The story of David’s Arthur, or Arturius as he was referred to by the monks, is almost identical to that of the legendary king we all know today.

Arturius was the son of a 6th century Scottish king called Aiden.

David said:

“There is no doubt in my mind that Arturius is the real King Arthur.

Both were active in the 6th century, both died in battles against the Picts, both were Christian, both fought alongside Urien and other British kings and both had a sister called Morgan – a name unheard of in 6th and 7th century records.

To have a brother and a sister at that time called Arthur and Morgan is highly unlikely. It would be like finding another Napoleon and Josephine or Antony and Cleopatra – it’s almost impossible.”

Arturius’ documentation in the manuscript came five centuries before Geoffrey of Monmouth introduced the story of Arthur into Cornish legend.

The distribution of the manuscript throughout Europe would explain why Arthur was known in mainland Europe centuries before being connected to Cornwall in the 12th century.

David believes the reason why, for centuries, this 6th century prince was overlooked as being the source of Arthurian legend is because he was referred to as a battle leader by the monks, not as a king.

David said:

“Arturius was referred to as a battle leader, never a king, but he was the son of a king. Had he not died in battle against the Picts, he could have eventually succeeded his father and become King Arturius – King Arthur.”

To add to David’s claims, most research into Arthurian legend dates back as far as a 9th century Welsh monk, Nennius, who also refers to Arthur as a battle leader – as per the Swiss manuscript written two centuries earlier.

David has written a book based on his research called ‘Arturius – A Quest for Camelot’ which is now available to download for free at:


For more information or media enquiries you can contact David at:

Email – dfcarroll@yahoo.com

Telephone number – +44(0)1482 842257

Notes to editors:

Dorbene Manuscript

The Dorbene manuscript or ‘Vita Columba’ was written by monks in the 7th century on the remote island of Iona, the birthplace of Christianity in northern Britain. It was then copied and transported to monasteries throughout Europe. The earliest known copy in Europe was made at the monastery of St.Gall in Switzerland, around the year 850 A.D. Today the original copy from Iona can be found under lock and key in the town library of Schaffhausen, Switzerland.

Arturius – A Quest for Camelot

David is keen to hear from anyone who thinks they can prove that King Arthur is based on someone other than the 6th century Scottish prince Arturius.

Like Arturius and the legendary King Arthur, they must have:

• been active in the 6th century
• had a sister called Morgan
• died in battle against the Picts
• been a Christian
• fought alongside Urien and other British kings.

David F Carroll
David Carroll Inc
01482 842257
email us here

Source: EIN Presswire

Clare Ardern Named JOSPT Editor-in-Chief

Clare L. Ardern, PT, PhD, has been appointed editor-in-chief (EIC) of the Journal of Orthopaedic & Sports Physical Therapy® (JOSPT®).

ALEXANDRIA, VIRGINIA, UNITED STATES, July 2, 2018 /EINPresswire.com/ — Clare L. Ardern, PT, PhD, has been appointed editor-in-chief (EIC) of the Journal of Orthopaedic & Sports Physical Therapy® (JOSPT®). The first woman to hold this position, Dr Ardern comes to JOSPT having served on the British Journal of Sports Medicine editorial team as deputy editor for systematic reviews.

Beginning July 1, 2018 and for the next year, Dr Ardern will work collaboratively as EIC Elect with Guy G. Simoneau, PT, PhD, ATC, FAPTA, who is currently serving as Interim EIC and previously led JOSPT as EIC for 14 years, from January 2002 through December 2015. Dr Ardern will start work with the JOSPT community by developing new reader- and patient-engagement initiatives for the Journal.

“We look forward to the knowledge, enthusiasm, and energy Dr Ardern brings to JOSPT,” said John A. Nyland, DPT, SCS, EdD, ATC, CSCS, FACSM, president of the JOSPT Board of Directors, which appointed Dr Ardern. “This is, indeed, an exciting time for the Journal, and our organization is fortunate to have such talented editorial leadership.”

“It’s a great honor and a privilege to lead JOSPT,” Dr Ardern said. “I encourage our readers to help shape the Journal and look forward to working together to apply this field’s best research to the care of our patients and athletes.”

Dr Ardern is an Australian physical therapist and sports medicine researcher. Her main research interests are return to sport after injury and how high-caliber meta-research (including systematic reviews, network meta-analyses, and clinical practice guidelines) can help clinicians make quality decisions in practice. For the past decade, her research has focused on understanding how clinicians can best help athletes and active people achieve their sports and physical activity participation goals after injury. Dr Ardern is an expert in outcomes following anterior cruciate ligament injury, with a special focus on how psychological factors influence those outcomes.

She is currently an Australian National Health and Medical Research Council Early Career Fellow in the Division of Physiotherapy at Linköping University in Sweden. In this full-time research position, Dr Ardern leads the development of a mobile application to support recreational athletes in their attempt to safely return to sport after injury. She also serves as a senior collaborator in clinical research on outcomes following treatment for tendinopathy and shoulder, hip, knee, and ankle problems. In addition, Dr Ardern supervises postgraduate research in lower extremity injuries, and is a guest lecturer and tutor in the sports medicine course for the Master of Physiotherapy program at Linköping University.

Since 2011, Dr Ardern has authored nearly 50 peer-reviewed and published articles, which have appeared in many of the leading orthopaedics and sports medicine journals, including JOSPT; British Journal of Sports Medicine; American Journal of Sports Medicine; Arthroscopy; Knee Surgery, Sports Traumatology, Arthroscopy; and Scandinavian Journal of Medicine and Science in Sports. In addition, she has served as a peer reviewer for more than a dozen journals.

Dr Ardern works with a diverse group of orthopaedics and sports researchers in different research settings, across several populations, and in many geographical regions. Her international leadership in sports physical therapy has involved bringing together professionals contributing to the multidisciplinary care of athletes and active people to produce the World Sports Physical Therapy Congress 2016 consensus statement on return to sport and the 2018 International Olympic Committee consensus statement on the prevention, diagnosis, and management of pediatric anterior cruciate ligament injuries. Each project involved more than 20 orthopaedics and sports medicine experts.

Dr Ardern holds both her bachelor's degree in physiotherapy with honors and her doctorate in orthopaedic sports medicine from La Trobe University in Melbourne, Australia. Before coming to Sweden, she worked as a postdoctoral researcher at Aspetar Orthopaedic and Sports Medicine Hospital in Doha, Qatar. She is a member of Sports Medicine Australia and Svensk Förening för Fysisk Aktivitet och Idrottsmedicin (Swedish Association for Physical Activity and Sports Medicine). Formerly an athlete in track and field and soccer, Dr Ardern continues to practice physical activity for a healthy life by biking daily, running, and playing team sports.

For more information, please contact JOSPT Executive Director/Publisher Edith Holmes at edithholmes@jospt.org, or visit https://www.jospt.org. JOSPT is published by JOSPT, Inc. d/b/a Movement Science Media.

Edith Holmes
email us here

Source: EIN Presswire

New Jersey Mesothelioma Victims Center Now Urges a Navy Veteran with Mesothelioma in New Jersey to Call for On the Spot Access to the Nation's Top Attorneys to Achieve the Top Financial Compensation Results

When it comes to mesothelioma compensation for a US Navy Veteran, it is incredibly important the attorney you hire has years of experience with Navy Veteran asbestos exposure cases.”

— New Jersey Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, July 2, 2018 /EINPresswire.com/ — The New Jersey Mesothelioma Victims Center is urging a US Navy Veteran who has just been diagnosed with mesothelioma, or their family to please call them anytime at 800-714-0303 so they do not mistakenly hire an inexperienced lawyer/law firm.

The group offers a Navy Veteran with this rare asbestos cancer direct access to some of the nation's most skilled mesothelioma attorneys who exclusively handle mesothelioma compensation claims on a full-time basis. The mesothelioma lawyers the group suggests frequently get million-dollar settlements for Navy Veterans with mesothelioma-especially if the Veteran was exposed to asbestos in a ship's engine room, engineering, or if they served on a nuclear submarine as they would like to discuss at 800-714-0303. http://NewJersey.MesotheliomaVictimsCenter.Com

The New Jersey Mesothelioma Victims Center says, "When it comes to mesothelioma compensation for a US Navy Veteran, it is incredibly important the attorney you hire has years of experience with Navy Veteran asbestos exposure cases. Hiring a local car-accident attorney or personal-injury attorneys to handle a complex mesothelioma compensation claim could result in a navy veteran with mesothelioma getting dramatically shortchanged as we would like to discuss anytime at 800-714-0303. When we mention shortchanged we are referring to hundreds of thousands of dollars-lost.” http://NewJersey.MesotheliomaVictimsCenter.Com

The New Jersey Mesothelioma Victims Center has experience helping US Navy Veterans who were exposed to asbestos on the following types of US Navy ships:

* Destroyers

* Frigates

* Air Craft Carriers

* Battleships (Used during the Vietnam War)

* Cruisers

* Fast Attack Submarines (Los Angeles Class)

* Boomers (Ohio Class Submarine)

* Amphibious Assault Ships

* Troop Transport Ships

* Oilers and Cargo Ships

* Navy Tugs/Support Vessels

For a listing of all former and current US Navy ships, please refer to the US Navy's website that addresses these topics. https://www.navy.com/life-in-the-navy/vessels.

The New Jersey Mesothelioma Victims Center wants to emphasize theirs is a statewide initiative available to a diagnosed Veteran or person anywhere in New Jersey, including communities such as Newark, Jersey City, Paterson, Elizabeth, Edison, Toms River, or Trenton. http://NewJersey.MesotheliomaVictimsCenter.Com

For the best possible treatment option in New Jersey, the New Jersey Mesothelioma Victims Center strongly recommends the following heath care facility with the offer to help a diagnosed victim or their family get to the right physicians at this hospital. The Rutgers University’s Cancer Institute of New Jersey in New Brunswick: http://www.cinj.org/

According to the CDC, the states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

High-risk work groups for exposure to asbestos in New Jersey include US Navy Veterans, power plant workers, oil refinery workers, manufacturing or industrial workers, chemical plant workers, plumbers, electricians, auto mechanics, machinists, mill workers, printers, welders, boiler technicians, or construction workers. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s or 1980’s. http://NewJersey.MesotheliomaVictimsCenter.Com

The Mesothelioma Victims Center is a national advocate 100% focused in on doing everything possible to ensure people with mesothelioma in every state receive the best possible financial compensation settlement. The group offers on the spot access to some of the nation’s most skilled and experienced mesothelioma attorneys because to receive the very best possible financial compensation a diagnosed person must be represented by the most capable mesothelioma lawyers in the United States as they would like to discuss anytime at 800-714-0303. http://MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma.

Michael Thomas
New Jersey Mesothelioma Victims Center
email us here

Source: EIN Presswire

Chairman Vinod Ramchandra Jadhav and His Team at SAVA Global Announce Latest Generation of Dry Powder Inhalers

SAVA Global is proud to announce the release of their next generation dry powder inhalers.

PUNE, MAHARASHTRA, INDIA, July 2, 2018 /EINPresswire.com/ — SAVA Global’s Research and Development Center has been working tirelessly to make the treatment of asthma and asthma-like symptoms easier, more effective, and more efficient. 

SAVA Global understands the importance of dry powder inhalers and has worked hard to make even more improvements on an already great product. SAVA’s Research and Development Center in Pune, India, aided by best-in-class research and development equipment like the Dosage Unit Sampling Apparatus (DUSA), NextGen Impactor (NGI), and Glass Twin Impinger (T1, T2), are ready to announce their new DPI’s: Tiotropium, Formoterol, salmeterol/fluticasone, and Budesonide/Formoterol Fumarate.

Within the global healthcare market, research and development of dry powder inhalers (DPI’s) continue to grow immensely. Many attribute this to their effectiveness, some to their ease of use, but the biggest catalyst for this demand for more and better DPI’s is the increasing incidence of chronic obstructive pulmonary disease (COPD). DPI’s provide a much more efficient delivery system for asthma treatment, an efficiency that is fast becoming a necessity as more people are showing symptoms of COPD across the globe. By easing the delivery of medication through pulmonary routes, COPD sufferers using DPI’s can avoid the potential complications caused by traditional delivery systems.

Under the leadership of Vinod Ramchandra Jadhav, SAVA Global has developed these new dry powder inhalers based on scientific research and data to make them better for everyone who needs them. SAVA’s new DPI’s are easy to use, compact, and efficient. Dry powder inhalers are a great alternative to traditional aerosol-based inhalers (MDI’s) because they deliver medication without requiring the user to coordinate his or her breath with the inhaler. Because they use dry powder, DPI’s can deliver treatment to the lungs more quickly. People suffering from asthma, bronchitis, emphysema, and COPD can receive their treatment quicker, easier, and much more effectively.

With the announcement of these new DPI’s, SAVA Global continues to establish itself as a trailblazer in the healthcare market. SAVA Global is looking toward the future and creating a path to innovation that everyone can follow.

For more information visit: http://www.savaglobal.com/

About Vinod Ramchandra Jadhav: Mr. Jadhav is a first generation entrepreneur with a passion for business. In 2001, he began operating as a franchises owner of a “Medicine Shoppe International” where he learned the ropes of the pharmaceutical industry and got the experience he needed to apply his knowledge of supply chain management on a larger scale. In 2003, he started SAVA Group and has grown the company into an international powerhouse that has footprints in 35 countries around the world. Since then Jadhav has taken his talents to several companies. In addition to being Chairman of SAVA Global, he is Chairman of DEVTECH M2M Group, Director of GangaGen Inc. and Managing Director of Regent Global FZCo.

Vinod Ramchandra Jadhav
SAVA Healthcare Limited
email us here

Source: EIN Presswire